- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05114174
Evaluation and Implementation of an mHealth Intervention Called Mami-educ to Fight Against Gestational Obesity
Evaluation and Implementation of an mHealth Intervention to Prevent Gestational Obesity in the Metropolitan Region and the Aconcagua Valley.
The World Federation of Obesity warns that the main health problem of the next decade will be childhood obesity. Furthermore, obesity and its consequences have been reported to originate in intrauterine life. Gestational obesity produces profound effects on fetal genome programming, thereby inducing changes in prenatal metabolism that extend to the postnatal period, which is also associated with increased susceptibility to developing cardiovascular and metabolic diseases in adulthood.
Excessive maternal weight gain early in pregnancy has been repeatedly associated with increased adiposity in childhood and adolescence of its offspring. Obesity is a complex phenomenon influenced by social determinants of health, which include demographic, socioeconomic, behavioral, environmental, and genetic factors. At the primary prevention level, nutrition constitutes a modifiable risk factor during pregnancy. Therefore establishing healthy nutritional behaviors during the first trimester of pregnancy is key to the primary prevention of the intergenerational transmission of obesity.
New ways of approaching the target population are required to maintain nutritional recommendations as a priority in the daily decision-making (top of mind) of pregnant women. For many women, this period is a powerful motivator for self-care.
Interventions based on behavioral theories provide a better understanding of the underlying mechanisms that determine health-related behavior change and have the potential to be more effective in promoting adherence to weight gain control. Social Cognitive Theory (TCS) is an integrated model of behavior change commonly applied in mobile health interventions that address diet, physical activity or weight loss.
Mobile health programs (mHealth) are potentially more effective than face-to-face interventions, especially during a public health emergency like the COVID-19 outbreak. This proposal intends to "deliver" messages with evidence-based information directly to pregnant women, in order to influence their nutritional behavior to avoid excessive gestational weight gain.
The hypothesis of this proposal is that the mHealth intervention called "mami-educ", which consists of sending messages with nutrition counseling during pregnancy through the Telegram platform, is effective in reducing excessive gestational weight gain in pregnant women attending Family Health Care Centers in an urban and predominantly rural area.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Delia I Chiarello, Ph.D.
- Phone Number: +56965774469
- Email: delia.chiarello@uss.cl
Study Locations
-
-
Providencia
-
Santiago, Providencia, Chile
- Recruiting
- Delia I Chiarello
-
Contact:
- Delia I Chiarello, Ph.D.
- Phone Number: +56965774469
- Email: delia.chiarello@uss.cl
-
Principal Investigator:
- Delia I Chiarello, Ph.D.
-
Sub-Investigator:
- Jessica Moya, Msc
-
-
Valparaíso
-
San Felipe, Valparaíso, Chile
- Recruiting
- Fabián Pardo
-
Contact:
- Fabián Pardo, Ph.D.
- Email: fabian.pardo@uv.cl
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Pregnant women who receive care in the 6 CESFAMs of El Bosque and Aconcagua Valley over 18 years of age; pregnant women with gestational age ≤ 12 weeks of gestation (first trimester)
- Pregnant women with a single pregnancy
- Healthy pregnant women
- Chilean or immigrant women who speak Spanish
- The participants must have a mobile device that allows the use of the Telegram application
- Pregnant women who agree to be randomized
- Pregnant women who have voluntarily signed the informed consent to participate in this study
Exclusion Criteria:
- A multiple pregnancy
- Conditions that require a special diet
- Participants with psychiatric illness or other pre-pregnancy pathology
- History of recurrent abortions
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Usual care group
Pregnant women enrolled in the prenatal control program who receive routine medical care.
|
|
Experimental: mami-educ group
Pregnant women enrolled in the prenatal care program who receive routine medical care and nutritional messages mom-educ.
|
The intervention corresponds to sending 3 messages a week through Telegram, with nutritional information, for 12 consecutive weeks (a different nutritional topic each week).
The messages address the three domains of learning, cognitive, affective, and psychomotor for each topic.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gestational weight gain
Time Frame: Nine months
|
Maternal weight gain measure in kilograms by month
|
Nine months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maternal outcome
Time Frame: Nine months
|
Medical diagnosis of of either preeclampsia, gestational diabetes or gestational hypertension
|
Nine months
|
Perinatal outcome
Time Frame: At birth
|
Labor delivery week
|
At birth
|
Apgar score
Time Frame: At birth
|
Apgar score report
|
At birth
|
Newborn birth weight
Time Frame: At birth
|
Newborn birth weight measure in grams
|
At birth
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Delia I Chiarello, Ph.D, Universidad San Sebastian
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SA21I0099
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gestational Weight Gain
-
University of Colorado, DenverEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
T.C. ORDU ÜNİVERSİTESİEge UniversityCompletedGestational Weight GainTurkey
-
University of HawaiiCompletedGestational Weight GainUnited States
-
Helena PiccininiNova Scotia Health AuthorityWithdrawnGestational Weight GainCanada
-
West China HospitalWest China Second University HospitalCompleted
-
Andalas UniversityNational Institute of Health Research and Development, Ministry of Health...CompletedBirth Weight | Pregnancy Weight GainIndonesia
-
Technical University of MadridCompleted
-
Arizona State UniversityKripalu Center for Yoga and HealthCompletedWeight GainUnited States
-
International Centre for Diarrhoeal Disease Research...Obstetrical and Gynaecological Society of Bangladesh (OGSB)Active, not recruiting
Clinical Trials on mami-educ
-
Oregon Research InstituteCompletedSubstance Use Disorder | DelinquencyUnited States
-
Canadian Institutes of Health Research (CIHR)Completed